Zura Financial Statements From 2010 to 2025

ZURA Stock   1.55  0.05  3.33%   
Zura Bio financial statements provide useful quarterly and yearly information to potential Zura Bio Limited investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Zura Bio financial statements helps investors assess Zura Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Zura Bio's valuation are summarized below:
Market Capitalization
295.8 M
Earnings Share
0.57
We have found seventy-nine available fundamental gauges for Zura Bio Limited, which can be analyzed and compared to other ratios and to its peers. All investors should make sure to confirm all of Zura Bio Limited prevalent market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road.
Check Zura Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zura Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 168.8 K, Other Operating Expenses of 75.6 M or Total Operating Expenses of 75.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.65. Zura financial statements analysis is a perfect complement when working with Zura Bio Valuation or Volatility modules.
  
Check out the analysis of Zura Bio Correlation against competitors.

Zura Bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets90.6 M116 M31.6 M
Slightly volatile
Other Current Liabilities11 M20.2 M3.9 M
Slightly volatile
Total Current Liabilities12.9 M23.3 M4.5 M
Slightly volatile
Accounts Payable1.7 M3.2 M609.5 K
Slightly volatile
Cash120.5 M114.8 M24.5 M
Slightly volatile
Non Currrent Assets Other154.5 M162.7 M142.1 M
Slightly volatile
Cash And Short Term Investments120.5 M114.8 M24.5 M
Slightly volatile
Common Stock Shares Outstanding24.8 M38 M20 M
Slightly volatile
Liabilities And Stockholders Equity121.8 M116 M25 M
Slightly volatile
Non Current Liabilities Total846.5 K891 K9.8 M
Slightly volatile
Other Current Assets611.9 K1.2 M507.8 K
Slightly volatile
Total Liabilities13.3 M24.5 M4.6 M
Slightly volatile
Total Current Assets121.8 M116 M24.7 M
Slightly volatile
Capital Stock3.4 K3.6 K113.4 M
Slightly volatile
Common Stock3.4 K3.6 K113.4 M
Slightly volatile
Short and Long Term Debt Total284.5 K320 K348.9 K
Slightly volatile
Deferred Long Term Liabilities2.8 M3.1 M3.4 M
Slightly volatile
Short and Long Term Debt284.5 K320 K348.9 K
Slightly volatile
Short Term Debt284.5 K320 K348.9 K
Slightly volatile

Zura Bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization168.8 K151.1 K222.2 K
Slightly volatile
Other Operating Expenses75.6 M72 M14.1 M
Slightly volatile
Total Operating Expenses75.6 M72 M14.1 M
Slightly volatile
Net Interest Income2.6 M2.5 M459.2 K
Slightly volatile
Interest Income2.6 M2.5 M459.2 K
Slightly volatile
Selling General Administrative11.7 M21.4 M5.4 M
Slightly volatile
Research Development37.2 M50.6 M27.5 M
Slightly volatile
Minority Interest173.6 K182.7 K1.3 M
Slightly volatile

Zura Bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings6.6 M7.5 M8.1 M
Slightly volatile
Other Cashflows From Financing Activities18 M17.1 MM
Slightly volatile
Change To Account Receivables2.3 K2.6 K2.8 K
Slightly volatile
Total Cash From Financing Activities70.1 M109.2 M124.7 M
Slightly volatile
End Period Cash Flow120.5 M114.8 M21.5 M
Slightly volatile
Change To Netincome27.2 M20.6 M39.6 M
Slightly volatile
Change To Liabilities2.4 M4.7 M1.1 M
Slightly volatile
Stock Based Compensation11.7 M11.1 M2.3 M
Slightly volatile
Begin Period Cash Flow1.3 M1.8 M882 K
Slightly volatile
Issuance Of Capital Stock69.5 M133.9 M28.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Book Value Per Share2.672.171.1154
Slightly volatile
Cash Per Share2.852.720.7421
Slightly volatile
Current Ratio5.435.7191.7761
Slightly volatile
Tangible Book Value Per Share2.672.171.1154
Slightly volatile
Graham Number8.117.733.0044
Slightly volatile
Capex Per Share0.520.280.6303
Slightly volatile
Interest Debt Per Share0.01650.01860.0202
Slightly volatile
Debt To Assets0.0020.00230.0025
Slightly volatile
Quick Ratio5.435.7191.7761
Slightly volatile
Net Income Per E B T0.80.90.9783
Slightly volatile
Cash Ratio5.375.6591.7653
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.671.7610.2259
Slightly volatile
Debt Ratio0.0020.00230.0025
Slightly volatile

Zura Bio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap115.1 M129.4 M141.1 M
Slightly volatile
Enterprise Value35.2 M39.6 M43.2 M
Slightly volatile

Zura Fundamental Market Drivers

Cash And Short Term Investments99.8 M

Zura Upcoming Events

26th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Zura Bio Financial Statements

Zura Bio stakeholders use historical fundamental indicators, such as Zura Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Zura Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Zura Bio's assets and liabilities are reflected in the revenues and expenses on Zura Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Zura Bio Limited. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-320 K-336 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Zura Bio Limited offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zura Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zura Bio Limited Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zura Bio Limited Stock:
Check out the analysis of Zura Bio Correlation against competitors.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zura Bio. If investors know Zura will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zura Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.57
Return On Assets
(0.21)
Return On Equity
(0.37)
The market value of Zura Bio Limited is measured differently than its book value, which is the value of Zura that is recorded on the company's balance sheet. Investors also form their own opinion of Zura Bio's value that differs from its market value or its book value, called intrinsic value, which is Zura Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zura Bio's market value can be influenced by many factors that don't directly affect Zura Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zura Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zura Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zura Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.